000 01532 a2200445 4500
005 20250513210900.0
264 0 _c20000504
008 200005s 0 0 eng d
022 _a0036-8075
024 7 _a10.1126/science.288.5466.627
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAnderson, W F
245 0 0 _aGene therapy. The best of times, the worst of times.
_h[electronic resource]
260 _bScience (New York, N.Y.)
_cApr 2000
300 _a627-9 p.
_bdigital
500 _aPublication Type: Comment; Journal Article
650 0 4 _aAdenosine Deaminase
_xdeficiency
650 0 4 _aAntigens, CD34
_xanalysis
650 0 4 _aCardiovascular Diseases
_xtherapy
650 0 4 _aChild, Preschool
650 0 4 _aClinical Trials as Topic
650 0 4 _aFemale
650 0 4 _aGenetic Linkage
650 0 4 _aGenetic Therapy
_xadverse effects
650 0 4 _aGenetic Vectors
650 0 4 _aHematopoietic Stem Cell Transplantation
650 0 4 _aHematopoietic Stem Cells
650 0 4 _aHemophilia A
_xtherapy
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aLymphocyte Count
650 0 4 _aNeovascularization, Physiologic
650 0 4 _aReceptors, Interleukin
_xbiosynthesis
650 0 4 _aSevere Combined Immunodeficiency
_xenzymology
650 0 4 _aT-Lymphocytes
_xenzymology
650 0 4 _aTransfection
650 0 4 _aX Chromosome
773 0 _tScience (New York, N.Y.)
_gvol. 288
_gno. 5466
_gp. 627-9
856 4 0 _uhttps://doi.org/10.1126/science.288.5466.627
_zAvailable from publisher's website
999 _c10751295
_d10751295